Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rhDNase on neutrophil protease distribution in sputum from adults with cystic fibrosis
2008-005462-32Phase 4Active
- Sponsor
- CHRU Tours
- Start
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dornase alfa in cystic fibrosis (CF), sponsored by CHRU Tours. Primary endpoint: Neutrophil protease activity in sputum. Started Oct 2008; status: active.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2008-005462-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005462-32.